CoChat

Cholangiocyte‐Derived Exosomal Long Noncoding RNA H19 Promotes Hepatic Stellate Cell Activation and Cholestatic Liver Fibrosis

Open access
Liu, Runping, Li, Xiaojiaoyang, Zhu, Weiwei, Wang, Yanyan, Zhao, Derrick, Wang, Xuan, Gurley, Emily C., Liang, Guang, Chen, Weidong, Lai, Guanhua, Pandak, William M., Robert Lippman, H., Bajaj, Jasmohan S., Hylemon, Phillip B., Zhou, Huiping · 2019 · Hepatology
Cited by 221

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Activation of hepatic stellate cells (HSCs) represents the primary driving force to promote the progression of chronic cholestatic liver diseases. We previously reported that cholangiocyte‐derived exosomal long noncoding RNA‐H19 (lncRNA‐H19) plays a critical role in promoting cholestatic liver injury. However, it remains unclear whether cholangiocyte‐derived lncRNA‐H19 regulates HSC activation, which is the major focus of this study. Both bile duct ligation (BDL) and Mdr2 knockout (Mdr2‐/‐) mouse models were used. Wild‐type and H19 maternalΔExon1/+ (H19KO) mice were subjected to BDL. Mdr2‐/‐H19 maternalΔExon1/+ (DKO) mice were generated. Exosomes isolated from cultured mouse and human cholangiocytes or mouse serum were used for in vivo transplantation and in vitro studies. Fluorescence‐labeled exosomes and flow cytometry were used to monitor exosome uptake by hepatic cells. Collagen gel contraction and bromodeoxyuridine assays were used to determine the effect of exosomal‐H19 on HSC activation and proliferation. Mouse and human primary sclerosing cholangitis (PSC)/primary biliary cholangitis (PBC) liver samples were analyzed by real‐time PCR, western blot analysis, histology, and immunohistochemistry. The results demonstrated that hepatic H19 level was closely correlated with the severity of liver fibrosis in both mouse models and human patients with PSC and PBC. H19 deficiency significantly protected mice from liver fibrosis in BDL and Mdr2‐/‐ mice. Transplanted cholangiocyte‐derived H19‐enriched exosomes were rapidly and preferentially taken up by HSCs and HSC‐derived fibroblasts, and promoted liver fibrosis in BDL‐H19KO mice and DKO mice. H19‐enriched exosomes enhanced transdifferentiation of cultured mouse primary HSCs and promoted proliferation and matrix formation in HSC‐derived fibroblasts. Conclusion: Cholangiocyte‐derived exosomal H19 plays a critical role in the progression of cholestatic liver fibrosis by promoting HSC differentiation and activation and represents a potential diagnostic biomarker and therapeutic target for cholangiopathies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hep.30662

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 221

Metadata

Authors
Liu, R., Li, X., Zhu, W., Wang, Y., Zhao, D., Wang, X., Gurley, E. C., Liang, G., Chen, W., Lai, G., Pandak, W. M., Robert Lippman, H., Bajaj, J. S., Hylemon, P. B., & Zhou, H.
Venue
Hepatology
Published
2019-05-24
Volume
70
Issue
4
Pages
1317-1335
ISSN
  • 0270-9139 (ISSN-L)
  • 1527-3350
OpenAlex
W2937857319
Cited by
221
References
5
FWCI
14.77
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cholangiocyte‐Derived Exosomal Long Noncoding RNA H19 Promotes Hepatic Stellate Cell Activation and Cholestatic Liver Fibrosis. https://app.cochat.ai/papers/10.1002/hep.30662
The paper
Liu, R., Li, X., Zhu, W., Wang, Y., Zhao, D., Wang, X., Gurley, E. C., Liang, G., Chen, W., Lai, G., Pandak, W. M., Robert Lippman, H., Bajaj, J. S., Hylemon, P. B., & Zhou, H. (2019). Cholangiocyte‐Derived Exosomal Long Noncoding RNA H19 Promotes Hepatic Stellate Cell Activation and Cholestatic Liver Fibrosis. Hepatology. https://doi.org/10.1002/hep.30662

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.